High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$800K
$800,000
Total Sells (Filtered)
$1.5M
$1,547,535
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
Director
Discretionary Buy
|
2026-02-27 | $300,000 | P | Form 4 |
|
PVLA
P
PALVELLA THERAPEUTICS, INC.
JENKINS GEORGE M
• Director
Discretionary Buy
2026-02-27
$500,000
|
||||||
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
Director
Discretionary Buy
|
2026-02-27 | $500,000 | P | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
Other
|
2026-02-18 | $34,883x2 | M | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
10b5-1 SellΔOwn -70.3%
|
2026-02-18 | $341,564x2 | S | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
Other
|
2026-01-21 | $34,883x2 | M | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
10b5-1 SellΔOwn -12.8%
|
2026-01-21 | $419,983x2 | S | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
Equity Compensation
|
2025-12-17 | $34,883x4 | M | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
10b5-1 Sell
|
2025-12-17 | $415,023 | S | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
Other
|
2025-11-19 | $34,883x2 | M | Form 4 |
| PVLA |
PALVELLA THERAPEUTICS, INC.
|
COO
10b5-1 SellΔOwn -34.9%
|
2025-11-19 | $370,965x2 | S | Form 4 |